MEI Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 42.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.4%	Anson Group	1,093,183	US$3.2m	0%	0.39%
9.18%	Cable Car Capital LLC	611,441	US$1.8m	0%	2.02%
5.85%	The Vanguard Group, Inc.	389,807	US$1.1m	0%	no data
2.25%	Acadian Asset Management LLC	150,150	US$435.4k	-29.1%	no data
2.18%	Renaissance Technologies LLC	145,292	US$421.3k	1.54%	no data
1.12%	BlackRock, Inc.	74,668	US$216.5k	-9.62%	no data
1.02%	GreenWood Investors, LLC	67,733	US$196.4k	0%	no data
0.77%	Geode Capital Management, LLC	51,290	US$148.7k	-2.18%	no data
0.5%	National Bank Investments Inc.	33,000	US$95.7k	43.5%	no data
0.45%	Macquarie Investment Management Business Trust	29,999	US$87.0k	0%	no data
0.4%	Bridgeway Capital Management, LLC	26,869	US$77.9k	0%	no data
0.35%	Northern Trust Global Investments	23,035	US$66.8k	-0.09%	no data
0.27%	State Street Global Advisors, Inc.	17,821	US$51.7k	0%	no data
0.26%	Squarepoint OPS LLC	17,532	US$50.8k	0%	no data
0.25%	Dimensional Fund Advisors LP	16,572	US$48.1k	-2.3%	no data
0.24%	Citadel Advisors LLC	15,887	US$46.1k	2,200%	no data
0.15%	Susquehanna International Group, LLP, Asset Management Arm	10,299	US$29.9k	-85.6%	no data
0.14%	Steven Wood	9,359	US$27.1k	115%	no data
0.12%	UBS Asset Management AG	8,100	US$23.5k	88.5%	no data
0.12%	James Flynn	7,900	US$22.9k	0%	no data
0.088%	Morgan Stanley, Investment Banking and Brokerage Investments	5,858	US$17.0k	-0.17%	no data
0.083%	Charles Baltic	5,555	US$16.1k	0%	no data
0.056%	Tower Research Capital Europe Limited	3,755	US$10.9k	94.5%	no data
0.042%	Group One Trading LP, Asset Management Arm	2,818	US$8.2k	-22.5%	no data
0.037%	David Urso	2,464	US$7.1k	0%	no data